|
Articulos -
Tratamientos
|
|
Escrito por Administrator
|
|
THURSDAY 10 de DECEMBER de 2009 17:02 |
| Publicaciones Recientes en Texto Completo
Disponibles en página web de AMMOM A.C.
www.ammom.com.mxThe effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial G.J. van Londen,S. Perera, K.T. Vujevich, S.M. Sereika, R. Bhattacharya, S.L. Greenspan Bone (2009), doi:10.1016/j.bone.2009.10.019
|
- Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years J.Y. Reginster, O. Bruyère, A. Sawicki, A. Roces-Varela, P. Fardellone, A. Roberts, J.P. Devogelaer Bone 45 (2009) 1059–1064
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Sarah J. Glover, Richard Eastell, Eugene V. McCloskey, Angela Rogers, Patrick Garnero,Jonathan Lowery, Rossella Belleli, Timothy M. Wright, Markus R. John. Bone 45 (2009) 1053–1058
- Risedronate on 2 Consecutive Days a Month Reduced Vertebral Fracture Risk at 1 Year Compared With Historical Placebo Nelson B. Watts,, Jacques P. Brown, and Gary Cline Journal of Clinical Densitometry: Assessment of Skeletal Health, 2009, DOI: 10.1016/j.jocd.2009.09.005
- Evidence for anti-osteoporosis therapy in acute fracture situations—Recommendations of a multidisciplinary workshop of the International Society for Fracture Repair. Jörg Goldhahn, David Little, Paul Mitchell, Nicola Fazzalari, Ian R. Reid, Per Aspenberg, David Marsh. Bone (2009), doi:10.1016/j.bone.2009.10.004
- Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body. Yan Chevalier,Evelyn Quek, Babul Borah, Gary Gross, John Stewart, Thomas Lang, Philippe Zysset.. Bone (2009),doi:10.1016/j.bone.2009.09.03
|
|
LAST_UPDATED2 |
Articulos 
